136 related articles for article (PubMed ID: 3016143)
1. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
Bolarin M
J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
[TBL] [Abstract][Full Text] [Related]
2. Serum enzymes of collagen synthesis and type III procollagen aminopropeptide in Nigerian patients with sickle cell disease.
Bolarin DM
J Natl Med Assoc; 1986 Jul; 78(7):613-6. PubMed ID: 3018272
[TBL] [Abstract][Full Text] [Related]
3. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
Bolarin DM; Andy JJ
Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity in breast tissues and sera of patients with primary breast cancer.
Bolarin DM
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):493-502. PubMed ID: 6304825
[TBL] [Abstract][Full Text] [Related]
6. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with hepato-cellular carcinoma and other malignant diseases.
Bolarin DM; Savolainen ER; Kivirikko KI
Int J Cancer; 1982 Apr; 29(4):401-5. PubMed ID: 6282764
[TBL] [Abstract][Full Text] [Related]
7. Three serum markers of collagen biosynthesis in Nigerians with cirrhosis and various infectious diseases.
Bolarin DM; Savolainen ER; Kivirikko KI
Eur J Clin Invest; 1984 Apr; 14(2):90-5. PubMed ID: 6329766
[TBL] [Abstract][Full Text] [Related]
8. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
9. [Serum type III procollagen N-terminal peptide in patients with collagen diseases].
Aoki A; Hagiwara E; Atsumi Y; Shirai A; Igarashi T; Narita M; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T
Ryumachi; 1990 Apr; 30(2):81-4. PubMed ID: 2173157
[TBL] [Abstract][Full Text] [Related]
10. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
Leonardi S; La Spina M; La Rosa M; Schilirò G
Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen in children with growth retardation.
Cinaz P; Hasanoglu E; Gökçora N; Dogukan S; Demir A
Mater Med Pol; 1994; 26(2):55-8. PubMed ID: 7745984
[TBL] [Abstract][Full Text] [Related]
12. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I
J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase III and collagen markers in serum following cross-country skiing.
Takala TE; Vuori JJ; Rahkila PJ; Hakala EO; Karpakka JA; Alen MJ; Orava YS; Väänänen HK
Med Sci Sports Exerc; 1989 Oct; 21(5):593-7. PubMed ID: 2532701
[TBL] [Abstract][Full Text] [Related]
14. Enzymes of collagen biosynthesis in skin and serum and dermatological diseases. II. Serum enzymes.
Kuutti-Savolainen ER
Clin Chim Acta; 1979 Aug; 96(1-2):53-8. PubMed ID: 225063
[TBL] [Abstract][Full Text] [Related]
15. Type IIA procollagen in development of the human intervertebral disc: regulated expression of the NH(2)-propeptide by enzymic processing reveals a unique developmental pathway.
Zhu Y; McAlinden A; Sandell LJ
Dev Dyn; 2001 Apr; 220(4):350-62. PubMed ID: 11307168
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
17. Activities of enzymes of collagen biosynthesis and levels of type III procollagen peptide in the serum of patients with sarcoidosis.
Poole A; Myllyla R; Davies BH
Life Sci; 1989; 45(4):319-26. PubMed ID: 2548048
[TBL] [Abstract][Full Text] [Related]
18. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man.
Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J
Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
20. Demonstration by immunofluorescence that the same cells from chick embryo aortas synthesize elastin and collagen types I and III.
Kao WW; Gay S; Bressan GM; Prockop DJ
Artery; 1980; 7(3):176-90. PubMed ID: 6258540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
